Sign in

CIK 0001661059

  • Non-accelerated filer
  • Smaller reporting company

NextCure, Inc.

Sign in to watch
Ticker
NXTC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
475231247
Phone
+1 240-399-4900
Business address
2850 QUARRY LAKE DRIVE, SUITE 280, BALTIMORE, MD, 21209
Open-market buys, last 90 days
$140,487
in 3 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$140,487. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ADAR1 Capital Management, LLC +$140K 10% owner 3 filings
Date Insider Transaction Shares Price Value Owned after
2019-06-13 SHANNON TIMOTHY M Director Grant or award · Stock Option (Right to Buy) +22,000 22,000
2019-05-13 SHANNON TIMOTHY M Director Conversion +445,866 445,866
2019-05-13 SHANNON TIMOTHY M Director Conversion +743,110 1,188,976
2019-05-13 SHANNON TIMOTHY M Director Conversion +729,599 1,918,575
2019-05-13 SHANNON TIMOTHY M Director Conversion +285,867 2,204,442
2019-05-13 SHANNON TIMOTHY M Director Purchase +50,000 $15.00 $750K 2,254,442
2019-05-13 SHANNON TIMOTHY M Director Conversion · Series A-1 Preferred Stock −3,582,000 0
2019-05-13 SHANNON TIMOTHY M Director Conversion · Series A-2 Preferred Stock −5,970,000 0
2019-05-13 SHANNON TIMOTHY M Director Conversion · Series A-3 Preferred Stock −5,861,455 0
2019-05-13 SHANNON TIMOTHY M Director Conversion · Series B-1 Preferred Stock −2,296,605 0

Page 1 of 1 · 10 trades